COVID-19 and diabetes: What have we learned so far?
- PMID: 32628128
- PMCID: PMC7385778
- DOI: 10.7861/clinmed.2020-0261
COVID-19 and diabetes: What have we learned so far?
Abstract
COVID-19 and diabetes are both pandemics with major impacts on global public health. While the response to COVID-19 has been rapid and progressive to reduce risk of harm, the response to the diabetes pandemic has been somewhat more muted. People with diabetes have been disproportionately affected by COVID-19, with growing evidence of higher mortality and morbidity. In this article, we discuss the impact of COVID-19 on our diabetes service in an urban area in the UK. We discuss the impact on our patients and ourselves, and the possible lessons we can carry into the future.
Keywords: COVID-19; Diabetes.
© Royal College of Physicians 2020. All rights reserved.
References
-
- Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China – key questions for impact assessment. N Engl J Med 2020;382:692–4. - PubMed
-
- Worldometer COVID-19 coronavirus pandemic. www.worldometers.info/coronavirus/ [Accessed 4 May 2020].
-
- International Diabetes Federation IDF Diabetes Atlas, 8th Edition. www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabe... [Accessed 4 May 2020].
